Radiofrequency ablation and stereotactic body radiotherapy for hepatocellular carcinoma: should they clash or reconcile?
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Rim, Chai Hong | - |
dc.contributor.author | Lee, Hye Yoon | - |
dc.contributor.author | Kim, Jung Sun | - |
dc.contributor.author | Kim, Hakyoung | - |
dc.date.accessioned | 2021-08-30T03:04:43Z | - |
dc.date.available | 2021-08-30T03:04:43Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2021-02-01 | - |
dc.identifier.issn | 0955-3002 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/49629 | - |
dc.description.abstract | Until a few decades ago, surgical resection was the only valid option for treating hepatocellular carcinoma (HCC). However, various locoregional modalities including arterial-directed therapy, radiofrequency ablation (RFA), and radiotherapy have been recently shown to be effective. RFA is now established as a standard treatment for small localized HCCs, showing oncological results comparable to those of surgical resection in randomized studies. Stereotactic body radiotherapy (SBRT) is a modern radiotherapeutic modality that targets tumors with precision and delivers high radiation doses over a short period of time; it has particularly attracted clinical interest after its therapeutic efficacy was found to be similar to that of surgery in early-stage lung cancer. Given its potent disease control capability, SBRT has also been applied to early HCCs and demonstrated promising results in recent studies. It has also been noted for its suitability to treat tumors located in anatomical locations where RFA would be challenging. However, since its effectiveness has not been compared to that of RFA in randomized studies of patients eligible for RFA, the use of SBRT has been debated. This review was conducted to guide physicians from all fields involved in the treatment of early HCC. The therapeutic characteristics and indications of both SBRT and RFA are described, and recent comparative studies between the two modalities are discussed. In addition, we examined the factors that should be considered when selecting the appropriate treatments, and offer our recommendations. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | TAYLOR & FRANCIS LTD | - |
dc.title | Radiofrequency ablation and stereotactic body radiotherapy for hepatocellular carcinoma: should they clash or reconcile? | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Rim, Chai Hong | - |
dc.contributor.affiliatedAuthor | Kim, Jung Sun | - |
dc.identifier.doi | 10.1080/09553002.2021.1857453 | - |
dc.identifier.scopusid | 2-s2.0-85097778539 | - |
dc.identifier.wosid | 000613870900001 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, v.97, no.2, pp.111 - 119 | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF RADIATION BIOLOGY | - |
dc.citation.title | INTERNATIONAL JOURNAL OF RADIATION BIOLOGY | - |
dc.citation.volume | 97 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 111 | - |
dc.citation.endPage | 119 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Life Sciences & Biomedicine - Other Topics | - |
dc.relation.journalResearchArea | Nuclear Science & Technology | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Biology | - |
dc.relation.journalWebOfScienceCategory | Nuclear Science & Technology | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.subject.keywordAuthor | Radiofrequency ablation | - |
dc.subject.keywordAuthor | stereotactic body radiotherapy | - |
dc.subject.keywordAuthor | hepatocellular carcinoma | - |
dc.subject.keywordAuthor | liver neoplasm | - |
dc.subject.keywordAuthor | stereotactic ablative body radiotherapy | - |
dc.subject.keywordAuthor | comparative studies | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.